Feasibility of a combination of high dose chemotherapy ifosfamide, carboplatin, etoposide (ICE) plus stem cells and bevacizumab in refractory sarcoma and germ cell tumors.

被引：0
|
作者：
Jordan, K [1 ]
Kegel, T [1 ]
Mueller, LP [1 ]
Kinitz, I [1 ]
Schmoll, HJ [1 ]
机构：
[1] Univ Halle Wittenberg, Halle Saale, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：833S / 833S
页数：1
相关论文
共 50 条
  • [41] Results with salvage chemotherapy with high dose carboplatin plus etoposide and peripheral blood stem cell transplant in male choriocarcinoma
    Brames, M.
    Papiani, G.
    Einhorn, L.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] Sequential high-dose-chemotherapy with 4 cycles paclitaxel, ifosfamide, carboplatin, etoposide (P-ICE) in relapsed/refractory male germ cell cancer: Final results with 15.8 years follow-up
    Schmoll, H. J. E-V.
    Kegel, T.
    Jordan, K.
    Meinert, F. M.
    Cygon, F.
    Hammad, K.
    ANNALS OF ONCOLOGY, 2024, 35 : S538 - S538
  • [43] Use of Ifosfamide, Carboplatin and Etoposide (ICE) as First Line Treatment of Pediatric Germ Cell Tumors in a Low-Middle Income Country
    Quinto Morales, G.
    Leal, C.
    Perez, D.
    PEDIATRIC BLOOD & CANCER, 2020, 67 : S196 - S197
  • [44] High dose chemotherapy with BICE (BCNU, ifosfamide, carboplatin, and etoposide) and autologous bone marrow transplantation for patients with Ewings Sarcoma (ES)
    Shaughnessy, P
    Ririe, D
    Osswald, M
    Lewis, S
    BLOOD, 1998, 92 (10) : 372B - 372B
  • [45] High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity
    Motzer, RJ
    Mazumdar, M
    Bosl, GJ
    Bajorin, DF
    Amsterdam, A
    Vlamis, V
    JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1098 - 1105
  • [46] Taxol, ifosfamide, and cisplatin (TIP) followed by high-dose chemotherapy with carboplatin, etoposide and thiotepa (HD-CET) in germ-cell cancer
    Rick, O
    Beyer, J
    Bokemeyer, C
    Metzner, B
    Casper, J
    Wandt, H
    Hartmann, F
    Schmoll, HJ
    Kanz, L
    Huhn, D
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1999, 23 : S192 - S192
  • [47] Treating relapsed and refractory metastatic germ cell tumours with high-dose chemotherapy with carboplatin and etoposide and autologous haematopoietic stem cell transplantation (Oct, 10.1177/1078155220964540, 2020)
    Erturk, I
    Karadurmus, N.
    Kiziloz, H.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (02) : NP1 - NP1
  • [48] HIGH FAILURE RATE OF CARBOPLATIN ETOPOSIDE COMBINATION IN GOOD RISK NONSEMINOMATOUS GERM-CELL TUMORS
    KATTAN, J
    MAHJOUBI, M
    DROZ, JP
    KRAMAR, A
    CULINE, S
    BOUTANLAROZE, A
    CHAZARD, M
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (11) : 1504 - 1509
  • [49] CUTANEOUS TOXICITY OF HIGH-DOSE CARBOPLATIN, ETOPOSIDE AND IFOSFAMIDE FOLLOWED BY AUTOLOGOUS STEM-CELL REINFUSION
    BEYER, J
    GRABBE, J
    LENZ, K
    WEISBACH, V
    STROHSCHEER, I
    HUHN, D
    SIEGERT, W
    BONE MARROW TRANSPLANTATION, 1992, 10 (06) : 491 - 494
  • [50] Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support
    Lotz, JP
    Izrael, V
    BONE MARROW TRANSPLANTATION, 1995, 16 (06) : 858 - 859
12345